Home » Topics » BioWorld Science

BioWorld Science
RSS

Genfit completes enrollment in phase IIa trial of elafibranor for primary biliary cholangitis

Aug. 28, 2018

FDA issues complete response letter for Waylivra NDA

Aug. 28, 2018

Sirtuin 6 is behind epigenetic melanoma drug resistance

Aug. 28, 2018

LEO Pharma discovers novel JAK1 inhibitor with high clearance and low bioavailability

Aug. 28, 2018

European Commission approves Mepsevii for non-neurological manifestations of MPS VII

Aug. 28, 2018

FDA approves Xerava to treat complicated intra-abdominal infections

Aug. 28, 2018

Grant supports further investigation of NVP-015 for genetic mitochondrial diseases

Aug. 28, 2018

Parasite protein protects mice from hemorrhagic cystitis by inducing IL-4 expression

Aug. 28, 2018

Sienna releases first-in-human study data on SNA-125 in psoriasis

Aug. 28, 2018

Bristol-Myers Squibb presents novel Nav1.7 inhibitor for the treatment of pain

Aug. 28, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...